Opsens Inc. develops, manufactures, installs, and sells fiber optic sensors for interventional cardiology, fractional flow reserve (FFR), oil and gas, and industrial applications. More Details
High growth potential with excellent balance sheet.
Share Price & News
How has Opsens's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: OPS is not significantly more volatile than the rest of Canadian stocks over the past 3 months, typically moving +/- 9% a week.
Volatility Over Time: OPS's weekly volatility (9%) has been stable over the past year.
7 Day Return
CA Medical Equipment
1 Year Return
CA Medical Equipment
Return vs Industry: OPS exceeded the Canadian Medical Equipment industry which returned 25.5% over the past year.
Return vs Market: OPS exceeded the Canadian Market which returned 39.2% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Opsens's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 month ago | Simply Wall StInvestors Who Bought Opsens (TSE:OPS) Shares A Year Ago Are Now Up 202%
2 months ago | Simply Wall StIs Opsens (TSE:OPS) Weighed On By Its Debt Load?
4 months ago | Simply Wall StOpsens Inc.'s (TSE:OPS) Shift From Loss To Profit
Is Opsens undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: OPS (CA$1.98) is trading below our estimate of fair value (CA$6.47)
Significantly Below Fair Value: OPS is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: OPS is poor value based on its PE Ratio (144x) compared to the North American Medical Equipment industry average (58.3x).
PE vs Market: OPS is poor value based on its PE Ratio (144x) compared to the Canadian market (15x).
Price to Earnings Growth Ratio
PEG Ratio: OPS is poor value based on its PEG Ratio (2.4x)
Price to Book Ratio
PB vs Industry: OPS's PB Ratio (4.9x) is in line with the CA Medical Equipment industry average.
How is Opsens forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: OPS's forecast earnings growth (59.8% per year) is above the savings rate (1.5%).
Earnings vs Market: OPS's earnings (59.8% per year) are forecast to grow faster than the Canadian market (13.4% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: OPS's revenue (28.6% per year) is forecast to grow faster than the Canadian market (6.3% per year).
High Growth Revenue: OPS's revenue (28.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if OPS's Return on Equity is forecast to be high in 3 years time
How has Opsens performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: OPS has a large one-off gain of CA$2.3M impacting its February 28 2021 financial results.
Growing Profit Margin: OPS became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: OPS has become profitable over the past 5 years, growing earnings by 32.6% per year.
Accelerating Growth: OPS has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: OPS has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (16.2%).
Return on Equity
High ROE: OPS's Return on Equity (2.9%) is considered low.
How is Opsens's financial position?
Financial Position Analysis
Short Term Liabilities: OPS's short term assets (CA$51.2M) exceed its short term liabilities (CA$7.1M).
Long Term Liabilities: OPS's short term assets (CA$51.2M) exceed its long term liabilities (CA$10.4M).
Debt to Equity History and Analysis
Debt Level: OPS's debt to equity ratio (20.3%) is considered satisfactory.
Reducing Debt: OPS's debt to equity ratio has reduced from 48.3% to 20.3% over the past 5 years.
Debt Coverage: OPS's debt is well covered by operating cash flow (37.6%).
Interest Coverage: Insufficient data to determine if OPS's interest payments on its debt are well covered by EBIT.
What is Opsens's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate OPS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate OPS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if OPS's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if OPS's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of OPS's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Mr. Louis Laflamme, C.A, C.P.A., has been the Chief Executive Officer and President of Opsens Inc. since January 7, 2013. Mr. Laflamme’s primary mandate is to see to the operational management of the Corpo...
CEO Compensation Analysis
Compensation vs Market: Louis's total compensation ($USD282.49K) is below average for companies of similar size in the Canadian market ($USD471.71K).
Compensation vs Earnings: Louis's compensation has been consistent with company performance over the past year.
Experienced Board: OPS's board of directors are considered experienced (6.3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 18.2%.
Opsens Inc.'s company bio, employee growth, exchange listings and data sources
- Name: Opsens Inc.
- Ticker: OPS
- Exchange: TSX
- Founded: NaN
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: CA$211.289m
- Shares outstanding: 106.71m
- Website: https://opsens.com
Number of Employees
- Opsens Inc.
- 750 Boulevard du Parc-Technologique
- G1P 4S3
Opsens Inc. develops, manufactures, installs, and sells fiber optic sensors for interventional cardiology, fractional flow reserve (FFR), oil and gas, and industrial applications. The company operates in t...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/05/15 23:43|
|End of Day Share Price||2021/05/14 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.